Methyl-CpG targeted transcriptional activation allows re-expression of tumor suppressor genes in human cancer cells

Shinichi Fukushige1, Emiko Kondo1, Akira Horii1

  • 1Department of Molecular Pathology, Tohoku University School of Medicine, 2-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi 980-8575, Japan.

Insights

Methyl-CpG Targeted Transcriptional Activation (MeTA) reactivates tumor suppressor genes in cancer without DNA demethylation. This epigenetic mechanism recruits coactivators to methylated promoters, offering a new strategy for identifying silenced genes.

Area of Science:

  • Epigenetics
  • Cancer Biology
  • Molecular Biology

Background:

  • Epigenetic silencing, involving DNA methylation and histone modifications, frequently inactivates tumor suppressor genes (TSGs) in cancer.
  • Current DNA methylation inhibitors can reactivate TSGs but often affect unmethylated genes.
  • Histone deacetylase inhibitors are generally less effective at reactivating TSGs.

Purpose of the Study:

  • To demonstrate the prevalence of methyl-CpG targeted transcriptional activation (MeTA) in human cancer.
  • To elucidate the mechanism by which MeTA reactivates TSGs without requiring DNA demethylation.
  • To establish an efficient method for identifying transcriptionally silenced genes, particularly TSGs and developmentally important genes.

Main Methods:

  • Analysis of MeTA in human cancer samples.
  • Investigating the recruitment of transcriptional coactivators to hypermethylated promoter regions via methyl-CpG binding domains (MBDs).
  • Assessing the reactivation of the MLH1 gene, including histone acetylation changes at its promoter.

Main Results:

  • MeTA was found to be widely present in human cancer, enabling TSG re-expression without DNA demethylation.
  • Transcriptional coactivators are recruited to hypermethylated TSG promoters through MBDs during MeTA.
  • Reactivation of MLH1 by MeTA was associated with histone H3 lysine 9/14 acetylation at the promoter.
  • All ten genes examined across three cell lines showed reactivation due to MeTA.

Conclusions:

  • MeTA provides an efficient mechanism for reactivating epigenetically silenced tumor suppressor genes in cancer.
  • The findings facilitate the identification of transcriptionally silenced genes with methylated CpG islands, including TSGs and crucial developmental genes.
  • MeTA represents a novel epigenetic regulatory pathway with significant implications for cancer therapy and developmental biology research.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...